Ippen H, Hofbauer M, Schauder S
Derm Beruf Umwelt. 1978;26(3):88-90.
The light sensitivity was determined on 14 psoriasis patients using two different light sources before, and after a three week period of systemic administration of 75 to 100 mg daily of the aromatic retinoid (ethyl ester of all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid, Ro 10-9359 [1]). The results indicate that with this therapy, the light sensitivity remains unchanged or even decreases; there is thus no contraindication to the simultaneous application of phototherapy and the systemic administration of this retinoic acid derivative.
在14名银屑病患者中，于全身每天服用75至100毫克芳香维甲酸（全反式-9-(4-甲氧基-2,3,6-三甲基苯基)-3,7-二甲基-2,4,6,8-壬四烯酸乙酯，Ro 10-9359 [1]）之前和为期三周的用药期之后，使用两种不同光源测定了光敏感性。结果表明，采用这种疗法，光敏感性保持不变甚至降低；因此，光疗与全身应用这种维甲酸衍生物同时进行并无禁忌。
